Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pf-06649751 (10 trials)
cvl-231 (5 trials)
cvl-865 (4 trials)
cvl-871 (1 trial)
pf-06412562 (1 trial)
alprazolam (xanax) (1 trial)
carbamazepine (tegretol) (1 trial)
carfentanyl (1 trial)
cvl-354 (2 trials)
cvl-936 (1 trial)
ly2795050 (1 trial)
Panic Disorder (Phase 1)
Parkinson Disease (Phase 3)
Schizophrenia (Phase 2)
Seizures (Phase 2)
Substance-Related Disorders (Phase 1)
Trials (24 total)
Trial APIs (11 total)